SynAct Pharma AB (OSTO:SYNACT) Days Payable: 0.00 (As of Mar. 2026)

What is SynAct Pharma AB Days Payable?

SynAct Pharma AB OSTO:SYNACT +14.40% 22 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates OSTO:SYNACT with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 705 Biotechnology companies, SynAct Pharma AB ranks worse than 141843.83% on this metric.

SynAct Pharma AB's average Accounts Payable for the three months ended in Mar. 2026 was kr8.02 Mil. SynAct Pharma AB's Cost of Goods Sold for the three months ended in Mar. 2026 was kr0.00 Mil.

The historical rank and industry rank for SynAct Pharma AB's Days Payable or its related term are showing as below:

OSTO:SYNACT's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.36
* Ranked among companies with meaningful Days Payable only.

SynAct Pharma AB's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

SynAct Pharma AB Days Payable Related Terms

SynAct Pharma AB Days Payable Historical Data

* Premium members only.

The historical data trend for SynAct Pharma AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SynAct Pharma AB Days Payable Chart

SynAct Pharma AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Days Payable

Get a 7-Day Free Trial

0.00

SynAct Pharma AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

OSTO:SYNACT vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, SynAct Pharma AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SynAct Pharma AB Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynAct Pharma AB's Days Payable distribution charts can be found below:

* The bar in red indicates where SynAct Pharma AB's Days Payable falls into.

Save Embed

22GF Score

SynAct Pharma AB OSTO:SYNACT

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

SynAct Pharma AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

SynAct Pharma AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

	Days Payable (A: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2024 )	+	Accounts Payable (A: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2025 )	*	Days in Period
=	( (17.347	+	9.486)	/	2 )	/	0	*	365
=	13.4165					/	0	*	365
=	N/A

SynAct Pharma AB's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (9.486	+	6.559)	/	2 )	/	0	*	365 / 4
=	8.0225					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

SynAct Pharma AB (OSTO:SYNACT) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SynAct Pharma AB and its competitors. According to the industry distribution chart, SynAct Pharma AB ranks #999999 out of 705 companies in the Biotechnology industry.

Is SynAct Pharma AB's Days Payable too high?

SynAct Pharma AB's current Days Payable is 0.00. Based on the distribution chart, SynAct Pharma AB ranks #999999 out of 705 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, SynAct Pharma AB has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.

How does SynAct Pharma AB's Days Payable compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, SynAct Pharma AB ranks #999999 out of 705 companies for Days Payable. This places SynAct Pharma AB in the lower half of its industry. The industry median Days Payable is 113.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SynAct Pharma AB and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SynAct Pharma AB's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is SynAct Pharma AB stock overvalued right now?

SynAct Pharma AB (OSTO:SYNACT) has a current Days Payable of 0.00. The current Days Payable is 0.00. SynAct Pharma AB's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For SynAct Pharma AB (OSTO:SYNACT), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SynAct Pharma AB Business Description

Industry Healthcare Biotechnology

Comparable Companies OSTO:IBT B OSTO:MVIR OSTO:XSPRAY OSTO:FLUO OSTO:ONCO XSAT:CESSA OSTO:CANTA OSTO:ALZCUR OSTO:SPRINT OSTO:CLBIO VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 8F8:Germany

Address Scheelevagen 2, Lund, SWE, 223 63

Website https://www.synactpharma.se

SynAct Pharma AB is a clinical-stage biotechnology company focused on resolving inflammation through the selective activation of the melanocortin system. The company has a broad portfolio of oral and injectable selective melanocortin agonists aimed at inducing anti-inflammatory and inflammation-resolution activity to help patients achieve immune balance and overcome inflammation. AP1189, the company's drug candidate, is being evaluated in three Phase 2 clinical programs regarding rheumatoid arthritis, idiopathic membranous glomerulonephritis and virus-induced respiratory failure.

22GF Score

Get the complete analysis for OSTO:SYNACT

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr21.05

Price

View OSTO:SYNACT Analysis

See Days Payable data for all stocks →